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204 Is 3-nitrotyrosine a marker of inﬂammation in airways of patients
with cystic ﬁbrosis?
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Nitrated tyrosine (3NT) has been detected in inﬂammatory diseases including cystic
ﬁbrosis (CF). Tyrosine nitration is thought to be mediated by the interaction of
the activated oxygen species, superoxide anion radical, with nitric oxide leading
to the generation of the nitrating species peroxinitrite. We analysed BAL ﬂuids
from patients with asthma and CF for 3NT-positive proteins. Concentrated BAL
ﬂuids were incubated with magnetic beads, coated with antibodies against 3NT,
and antibody-bound proteins identiﬁed after desorption by Western blotting and
MALDI-TOF. Human eosinophil peroxidase (EPO) was the only protein identiﬁed.
3NT staining of various immune cells in lung transplant tissues from CF patients
revealed that only eosinophils were positive for 3NT. Four eosinophil granule toxins,
including EPO were identiﬁed as 3NT-positive and high resolution MS demonstrated
the presence of a single surface-exposed nitrosylated tyrosine residues in three of
these toxins. However, 3NT-positive eosinophil granule toxins were also present
in blood eosinophils from healthy individuals. Further experiments using EPO−/−
mice, mice with a defect in NADPH oxidase, nitric oxide synthese KO mice
and patients with CGD demonstrated that the mechanism of tyrosine nitration is
mediated by EPO in the presence of hydrogen peroxide and a minute source of NO
or nitrite. These data suggest most if not all of the post-translationally modiﬁed
3NT-positive proteins are derived from eosinophils, suggesting that 3NT is not a
marker of inﬂammation but rather a marker of eosinophils in CF airways.
205 8-isoprostaglandinF-2-alfa in urine as a marker of oxidative
stress in cystic ﬁbrosis patients. A longitudinal study
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Several publications have shown that a state of oxidative stress exists in the lungs
of cystic ﬁbrosis(CF) patients. As the clinical effect on lung destruction is a
long term process we found it of interest to follow a marker of oxidative stress
(8-isoprostaglandinF-2-alfa) in the urine at monthly controls over a 6 months period,
to see if it might help to:
1. Evaluate which patients have a high degree of oxidative stress.
2. Evaluate urine samples as a practical paediatric tool to monitor effect and optimal
dosage of a future glutathion inhalation study.
As reactive oxygen species can be formed for example by the activation of
neutrophil granulocytes during bacterial infection, we found it important to have as
precise a description as possible of the inﬂammatory state of the patients. Therefore
the following parameters were followed monthly: CRP, Leucocyte count, Neutrophil
count, NO in expiration, Laryngeal suction or sputum culture, Antibiotics admin-
istered, FEV1, FVC, FEF 75/25, Urine 8-isoprostaglandinF-2-alfa.
With the knowledge that 8-isoprostaglandinF-2-alfa is a bronchoconstrictor we have
also made reversibility tests on all patients. Results will be presented.
206 Sputum eosinophils are elevated in CF patients with asthma
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Asthma complicating cystic ﬁbrosis (CF) is difﬁcult to diagnose due to similar
features of both lung diseases. CF lung inﬂammation is characterised by neutrophilic
inﬂammation, while asthma is regarded as an eosinophilic disease. Whether mea-
sures of inﬂammation differ and can be used for diagnosing CF-asthma remains to
be determined.
The aim of this study was to evaluate inﬂammatory markers in sputum in CF
patients with vs. without CF-asthma (CF-A).
CF-A was diagnosed by the presence of signiﬁcant reversibility of FEV1 with
b2-agonists and symptoms of bronchial hyperreactivity or frequent episodes of
wheezing. CF patients with allergic bronchopulmonary aspergillosis (ABPA) were
excluded. Induced sputum samples were obtained. Sputum eosinophil percentages
were calculated on total leukocyte count. IL-5, IL-17A and IFN-g mRNA levels
were determined with quantitative real-time RT-PCR.
39 adult patients were recruited: 13 (33.3%) had CF-A and 21 did not have CF-A,
5 patients were excluded for ABPA. FEV1 was 70.4±17.1% in CF-A patients
versus 66.7±18.8% in the non CF-A group (p = 0.48). We found signiﬁcantly
higher eosinophil percentages in the CF patients with CF-A compared to those
without (0.37±0.5% and 1.5±2.7%, respectively, p = 0.047). CF patients with
asthma also had a trend towards higher IL-5 and IL-17A mRNA levels (p = 0.16
and p = 0.12 respectively). IFN-g mRNA levels were comparable between the two
groups (p = 0.35).
We found elevated sputum eosinophil percentages and a Th2 and Th17 phenotype
in CF patients with CF-A. Measuring eosinophils in sputum could be a useful tool
to help diagnosing asthma in CF patients.
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Objectives: The proteolytic degradation of CF lung is mainly due to the serine pro-
teases secreted by activated neutrophils at inﬂammatory sites. But anti-inﬂammatory
therapies using antiproteases have not led to clinical application. Improvement of
the targetting of deleterious proteases requires a better understanding of how they
are regulated in the extracellular environment. We analyzed how the secretion of
Neutrophil Extracellular Traps (NETs) may inﬂuence activity of neutrophil serine
proteases and their regulation by protease inhibitors.
Methods: Neutrophils puriﬁed from control blood and CF sputum were challenged
with phorbol myristate acetate, A23187 or IL-8. Peptidase activities were measured
using speciﬁc FRET substrates. Extracellular DNA was quantiﬁed using a non-
permeant cell ﬂuorophore. DNA and proteases of NETs were analyzed by confocal
microscopy. The ATP dependance of NETs secretion was assayed using myxothiazol
and oxamate. Inhibition of NETs-bound proteases was measured using natural
inhibitors, a1-PI and antichymotrypsin.
Results and Conclusions: The three serine proteases (elastase, protease 3 and
cathepsin G) are bound to NETs secreted by metabolically active neutrophils.
NETs impair the inhibition of elastase and cathepsin G by natural inhibitors.
Inhibition is signiﬁcantly improved by DNase treatment in spite of the overall
increase of proteolytic activity. These results suggest that a combination of DNase
and antiproteases that target elastase and cathepsin G would improve the anti-
inﬂammatory therapies of lung inﬂammation.
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